20 小时
Medical Device Network on MSNSubtle Medical’s software solution gains CE mark for MRI imagingSubtle Medical has gained the CE mark certification in Europe for its software solution SubtleHD, designed to enhance the ...
13 小时
Zacks Investment Research on MSNHYPR Stock Jumps on NVIDIA Partnership to Advance AI NeuroimagingHyperfine, Inc. HYPR recently announced a strategic collaboration with NVIDIA to integrate advanced AI technologies into its ...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered ...
By the time I’d gotten to the MRI, I was cognitively overloaded.
Can VR reveal hidden biases? This study explores how virtual encounters trigger subconscious stereotypes and emotional ...
4 小时
Stockhead on MSNHealth Check: Emvision’s stroke detector takes to the skiesRoyal Flying Doctor Service paramedics have successfully tested Emvision's portable stroke detector, First Responder.
The "Europe Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report by Modality (CT/X-Ray, Ultrasound), Product (Iodinated Contrast Media, Microbubble), End Use, and ...
Neurodegenerative diseases represent a significant challenge in medical science, impacting millions globally. Despite advancements in diagnostic technology, ...
When a person's hearing and vision are uncompromised and function at a relatively high level, the human brain is able to take in various sights and ...
20 小时
AZoNano on MSNIron-Doped Boron Nitride Nanoparticles for Targeted Anastrozole DeliveryThis study reveals that Fe-doped boron nitride nanoparticles improve Anastrozole delivery, offering enhanced stability and targeted therapy for breast cancer.
17 小时
Verywell Health on MSNWhy Do I Have Watery Eyes (Epiphora), and What Helps?Epiphora describes excessive eye watering. Allergies, infection, or a clogged tear duct often cause it. Learn about causes, home remedies, and treatments.
20 小时
Clinical Trials Arena on MSNEnrolment concludes in Zealand’s Phase IIb obesity therapy trialZealand Pharma has concluded enrolment for its global, randomised Phase IIb ZUPREME-1 trial, assessing petrelintide.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果